Development Level

Tbio 14 | 11,445
Tchem 13 | 1,598
Tclin 8 | 613

Collection

GPCR: IDG Consortium (Targets) 1 | 126

IMPC Phenotype

embryonic lethality prior to t... 3 | 278
preweaning lethality, complete... 3 | 979
preweaning lethality, incomple... 3 | 499
abnormal eye morphology 2 | 68
decreased vertical activity 2 | 208
embryonic lethality prior to o... 2 | 239
increased circulating triglyce... 2 | 42
increased heart weight 2 | 62
microphthalmia 2 | 26
abnormal bone structure 1 | 187
abnormal embryo development 1 | 7
abnormal embryo turning 1 | 31
abnormal eye size 1 | 7
abnormal heart morphology 1 | 162
abnormal pericardium morpholog... 1 | 26
cataract 1 | 92
convulsive seizures 1 | 13
decreased circulating LDL chol... 1 | 38
decreased circulating alanine ... 1 | 47
decreased circulating serum al... 1 | 82
decreased circulating total pr... 1 | 49
decreased startle reflex 1 | 75
enlarged heart 1 | 210
hydrometra 1 | 53
hydrops fetalis 1 | 1
hyperactivity 1 | 148
impaired glucose tolerance 1 | 75
impaired pupillary reflex 1 | 26
improved glucose tolerance 1 | 79
increased circulating calcium ... 1 | 34
increased circulating choleste... 1 | 66
increased circulating creatini... 1 | 38
increased circulating insulin ... 1 | 3
increased circulating magnesiu... 1 | 10
increased circulating total pr... 1 | 28
increased fasted circulating g... 1 | 76
increased heart rate variabili... 1 | 7
increased kidney weight 1 | 6
increased mean platelet volume 1 | 45
increased startle reflex 1 | 112
limb grasping 1 | 41
mydriasis 1 | 6
prenatal lethality 1 | 28
prenatal lethality prior to he... 1 | 87
small superior vagus ganglion 1 | 74

Disease

Carcinoma 29 | 11,493
psoriasis 17 | 6,694
Schizophrenia 16 | 1,160
atypical teratoid / rhabdoid tumor 16 | 5,112
ependymoma 15 | 4,679
osteosarcoma 15 | 7,950
medulloblastoma, large-cell 14 | 6,241
glioblastoma 13 | 5,792
group 3 medulloblastoma 13 | 4,104
lung cancer 13 | 4,740
ovarian cancer 12 | 8,520
Alcoholic Intoxication, Chronic 11 | 289
Bipolar Disorder 11 | 666
Kidney cancer 10 | 2,613
lung carcinoma 10 | 2,843
primitive neuroectodermal tumor 10 | 3,035
Attention deficit hyperactivity disorder 9 | 278
Depressive disorder 9 | 409
Parkinson's disease 9 | 392
astrocytic glioma 9 | 2,597
Breast cancer 8 | 3,578
Mental Depression 8 | 333
Mood Disorders 8 | 184
non-small cell lung cancer 8 | 2,890
oligodendroglioma 8 | 2,850
Alcohol dependence 7 | 107
Astrocytoma, Pilocytic 7 | 3,081
Attention Deficit Disorder with Hyperactivity 7 | 21
Cancer 7 | 2,499
Major Depressive Disorder 7 | 301
Unipolar Depression 7 | 250
adult high grade glioma 7 | 3,801
Amphetamine-Related Disorders 6 | 74
Autistic Disorder 6 | 364
Epilepsy 6 | 792
pituitary cancer 6 | 1,972
Asthma 5 | 385
Epilepsy, Temporal Lobe 5 | 23
Hypertension 5 | 396
Hypotension 5 | 82
Intellectual disability 5 | 1,016
Liver cancer 5 | 604
Migraine 5 | 83
Pain 5 | 103
Seizures 5 | 596
Substance abuse 5 | 59
Vascular disease 5 | 319
interstitial cystitis 5 | 2,312
intraductal papillary-mucinous adenoma (IPMA) 5 | 2,955
lung adenocarcinoma 5 | 2,716
malignant mesothelioma 5 | 3,232
Acromegaly 4 | 51
Allergic rhinitis 4 | 94
Autosomal recessive predisposition 4 | 1,442
Cocaine-Related Disorders 4 | 92
Dysmenorrhea 4 | 21
Gilles de la Tourette syndrome 4 | 47
Huntington's disease 4 | 76
Hyperactive behavior 4 | 91
Hyperkinesis 4 | 32
Hypertensive disease 4 | 292
Melanoma 4 | 711
Movement Disorders 4 | 55
Nasal congestion 4 | 21
Nasal discharge 4 | 24
Obesity 4 | 678
Pathological gambling 4 | 15
Skin cancer 4 | 469
Substance Withdrawal Syndrome 4 | 55
Toxic encephalopathy 4 | 141
breast carcinoma 4 | 1,638
colon cancer 4 | 1,478
cutaneous lupus erythematosus 4 | 1,057
cystic fibrosis 4 | 1,696
diabetes mellitus 4 | 1,728
ductal carcinoma in situ 4 | 1,745
pediatric high grade glioma 4 | 1,064
subependymal giant cell astrocytoma 4 | 2,287
tuberculosis 4 | 2,010
Anxiety Disorders 3 | 38
Bronchitis 3 | 43
Chronic schizophrenia 3 | 16
Cocaine Dependence 3 | 51
Common cold 3 | 67
Conduct disorder 3 | 33
Dyskinesia, Drug-Induced 3 | 15
Heroin dependence 3 | 30
Hypertensive disorder 3 | 56
Kidney disease 3 | 430
Liver Cirrhosis, Experimental 3 | 769
Neoplasm Metastasis 3 | 168
Pick disease 3 | 1,894
Pulmonary emphysema 3 | 48
Spasticity 3 | 26
Substance-Related Disorders 3 | 115
Tremor 3 | 113
active Crohn's disease 3 | 922
esophageal adenocarcinoma 3 | 737
obsessive-compulsive disorder 3 | 61
pancreatic cancer 3 | 2,398

Tissue

Endocrine System 34 | 18,159
Female tissues 33 | 17,400
Nervous System 31 | 16,725
Skin and soft tissues 31 | 17,230
Digestive Tract 30 | 17,369
Male tissues 30 | 17,142
Blood and immune system 28 | 16,909
Liver and Pancreas 28 | 16,750
Respiratory system 28 | 16,393
Urinary Tract 27 | 16,678
Cardiovascular System 23 | 15,192

Target Family

GPCR 31 | 408
Non-IDG 4 | 12,091

PathwayCommons: inoh Pathway

http://pathwaycommons.org/pc2/... 35 | 35
http://pathwaycommons.org/pc2/... 236 | 236
http://pathwaycommons.org/pc2/... 235 | 235
http://pathwaycommons.org/pc2/... 233 | 233
http://pathwaycommons.org/pc2/... 224 | 224
http://pathwaycommons.org/pc2/... 224 | 224
http://pathwaycommons.org/pc2/... 223 | 223
http://pathwaycommons.org/pc2/... 223 | 223
http://pathwaycommons.org/pc2/... 183 | 183
http://pathwaycommons.org/pc2/... 178 | 178
http://pathwaycommons.org/pc2/... 173 | 173
http://pathwaycommons.org/pc2/... 173 | 173
http://pathwaycommons.org/pc2/... 123 | 123
http://pathwaycommons.org/pc2/... 96 | 96
http://pathwaycommons.org/pc2/... 85 | 85
http://pathwaycommons.org/pc2/... 63 | 63
http://pathwaycommons.org/pc2/... 60 | 60
http://pathwaycommons.org/pc2/... 58 | 58
http://pathwaycommons.org/pc2/... 56 | 56
http://pathwaycommons.org/pc2/... 56 | 56
http://pathwaycommons.org/pc2/... 56 | 56
http://pathwaycommons.org/pc2/... 56 | 56
http://pathwaycommons.org/pc2/... 56 | 56
http://pathwaycommons.org/pc2/... 55 | 55
http://pathwaycommons.org/pc2/... 51 | 51
http://pathwaycommons.org/pc2/... 49 | 49
http://pathwaycommons.org/pc2/... 48 | 48
http://pathwaycommons.org/pc2/... 47 | 47
http://pathwaycommons.org/pc2/... 47 | 47
http://pathwaycommons.org/pc2/... 47 | 47
http://pathwaycommons.org/pc2/... 47 | 47
http://pathwaycommons.org/pc2/... 47 | 47
http://pathwaycommons.org/pc2/... 47 | 47
http://pathwaycommons.org/pc2/... 45 | 45
http://pathwaycommons.org/pc2/... 44 | 44
http://pathwaycommons.org/pc2/... 43 | 43
http://pathwaycommons.org/pc2/... 43 | 43
http://pathwaycommons.org/pc2/... 42 | 42
http://pathwaycommons.org/pc2/... 40 | 40
http://pathwaycommons.org/pc2/... 40 | 40
http://pathwaycommons.org/pc2/... 40 | 40
http://pathwaycommons.org/pc2/... 40 | 40
http://pathwaycommons.org/pc2/... 38 | 38
http://pathwaycommons.org/pc2/... 37 | 37
http://pathwaycommons.org/pc2/... 36 | 36
http://pathwaycommons.org/pc2/... 36 | 36
http://pathwaycommons.org/pc2/... 35 | 35
http://pathwaycommons.org/pc2/... 35 | 35
http://pathwaycommons.org/pc2/... 34 | 34
http://pathwaycommons.org/pc2/... 30 | 30
http://pathwaycommons.org/pc2/... 30 | 30
http://pathwaycommons.org/pc2/... 29 | 29
http://pathwaycommons.org/pc2/... 29 | 29
http://pathwaycommons.org/pc2/... 28 | 28
http://pathwaycommons.org/pc2/... 27 | 27
http://pathwaycommons.org/pc2/... 27 | 27
http://pathwaycommons.org/pc2/... 24 | 24
http://pathwaycommons.org/pc2/... 24 | 24
http://pathwaycommons.org/pc2/... 24 | 24
http://pathwaycommons.org/pc2/... 24 | 24
http://pathwaycommons.org/pc2/... 24 | 24
http://pathwaycommons.org/pc2/... 24 | 24
http://pathwaycommons.org/pc2/... 22 | 22
http://pathwaycommons.org/pc2/... 21 | 21
http://pathwaycommons.org/pc2/... 21 | 21
http://pathwaycommons.org/pc2/... 21 | 21
http://pathwaycommons.org/pc2/... 21 | 21
http://pathwaycommons.org/pc2/... 20 | 20
http://pathwaycommons.org/pc2/... 20 | 20
http://pathwaycommons.org/pc2/... 20 | 20
http://pathwaycommons.org/pc2/... 20 | 20
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 18 | 18
http://pathwaycommons.org/pc2/... 18 | 18
http://pathwaycommons.org/pc2/... 18 | 18
http://pathwaycommons.org/pc2/... 18 | 18
http://pathwaycommons.org/pc2/... 18 | 18
http://pathwaycommons.org/pc2/... 18 | 18
http://pathwaycommons.org/pc2/... 18 | 18
http://pathwaycommons.org/pc2/... 17 | 17
http://pathwaycommons.org/pc2/... 17 | 17
http://pathwaycommons.org/pc2/... 17 | 17
http://pathwaycommons.org/pc2/... 17 | 17
http://pathwaycommons.org/pc2/... 17 | 17
http://pathwaycommons.org/pc2/... 16 | 16
http://pathwaycommons.org/pc2/... 16 | 16
http://pathwaycommons.org/pc2/... 16 | 16
http://pathwaycommons.org/pc2/... 16 | 16
http://pathwaycommons.org/pc2/... 16 | 16
http://pathwaycommons.org/pc2/... 16 | 16
http://pathwaycommons.org/pc2/... 15 | 15

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Smoothened homolog SMO Tclin GPCR -1.17466 14.5 415
Metabotropic glutamate receptor 3 GRM3 Tchem GPCR -2.30964 186.9 274
Metabotropic glutamate receptor 7 GRM7 Tchem GPCR -2.25415 190.8 304
Metabotropic glutamate receptor 4 GRM4 Tchem GPCR -2.34335 217.2 150
C-X-C chemokine receptor type 2 CXCR2 Tchem GPCR -2.87313 723.9 643
C-X-C chemokine receptor type 1 CXCR1 Tchem GPCR -2.48051 278.1 378
Metabotropic glutamate receptor 5 GRM5 Tchem GPCR -3.12353 1370.3 396
Frizzled-7 FZD7 Tbio GPCR -1.81873 66.4 345
D(1A) dopamine receptor DRD1 Tclin GPCR -2.55049 294.2 485
Metabotropic glutamate receptor 8 GRM8 Tchem GPCR -1.95032 89.4 286